BEIJING, April 18, 2024 /PRNewswire/ -- The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held in Glasgow, England on April 14-17, 2024.
Group photo of Lu Daopei's medical team at the EBMT meeting
Representatives of Lu Daopei's medical team brought 18 research results to the UK to participate in the conference, including 1 oral report, covering the most cutting-edge progress in the field of hematopoietic stem cell transplantation and cell immunotherapy and related research on clinical testing.
Dr. Xu Fang, from the Department of Bone Marrow Transplantation of Lu Daopei Hospital, made an oral speech on behalf of Professor Lu Yue's team at EBMT
当地时间，4月16日下午15：15，由陆道培医院骨髓移植科胥方医生代表卢岳主任团队在"Optimising donor Choice"环节中，口头汇报了"Comparing the Outcomes of Using Non-First-Degree Related Donors to First-Degree Related Donors in Haploidentical HSCT for Hematological Malignancies: A Case-Control Analysis"的临床研究成果，研究证实了在单倍体造血干细胞移植中，采用非直系供体在疗效及安全性方面均可以与直系供体相媲美，这也为临床上扩展单倍体移植供者的可选择范围提供了进一步的证据支持。 卢岳主任团队这一项研究受到了颇多关注。
Dr. Xu Fang's oral report was logical and well-organized, which not only demonstrated the professionalism of Lu Daopei's medical team, but also reflected the enthusiasm and pursuit of academic research among the young physicians in the team. The on-site experts showed great interest in the research results of Director Lu Yue's team, saying that this study has brought good news to patients without direct donors. It is worth mentioning that the oral presentations in this session are of high quality, and many of the reports cover the multi-center in-depth research related to the EBMT official website, and it is an honor to be selected for the oral reports of this session, which is enough to prove the outstanding performance of Lu Daopei's medical team in the field of transplantation, highlighting the broad vision and far-reaching influence of our team in academic research.
In addition to the oral presentations, 17 poster presentations by Lu Daopei's medical team were unveiled one after another, of which 12 reports were written by young physicians from the team. The hospital and department teams continue to optimize the talent training environment, strive to create conditions and build a platform for the growth of young doctors, encourage them to "go global", and continuously deepen their understanding of the medical field and improve their academic literacy by participating in domestic and international advanced training and international academic conferences, so as to build a team of young doctors with excellent quality and worthy of important responsibilities.
Think deeply and build the future together. Lu Daopei's medical team insists on going out, keeping up with the international frontier, focusing on the current difficult challenges in the field of hematology, constantly carrying out academic innovation, expanding clinical practice, optimizing diagnosis and treatment strategies, breaking through the "ceiling" of traditional treatment, and striving to maximize the treatment effect, bringing more hope and warmth to the majority of patients with hematology.
EBMT 2024 results at a glance Oral Presentation (ORAL)摘要号：959 第一作者：卢岳，通讯作者：卢岳 题目：Comparing the Outcomes of Using Non-First-Degree Related Donors to First-Degree Related Donors in Haploidentical HSCT for Hematological Malignancies: A Case-Control Analysis
Poster Presentation ( POSTER）摘要号：257 第一作者：朱会丽，通讯作者：魏志杰 题目：Efficacy and Safety Analysis of Prophylactic Basiliximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation
摘要号：284 第一作者：何海，通讯作者：孙瑞娟 题目：Intensive Conditioning Regimen for Allogeneic Hematopoietic Stem Cell can Overcome the Poor Prognosis of T(6; 9)/DEK-NUP214 AML
摘要号：391 第一作者：颜述，通讯作者：刘德琰 题目：The Clinical Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in Therapy-Related Myeloid Neoplasms
摘要号：733 第一作者：潘飞，通讯作者：魏志杰 题目：Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation Using Busulfan/Cyclophosphamide and Melphalan or Thiotepa as Conditioning Regimen in 37 Patients with Acute Megakaryoblastic Leukemia
摘要号：835 第一作者：赵艳丽，通讯作者：赵艳丽 题目：Allogeneic Transplantation Using Myeloablative Conditioning Regimes is Safe and Effective in Elderly Patients Over 60 Years with AML and MDS
摘要号：967 第一作者：同格乐 通讯作者：卢岳 题目：TLS∷ERG Fusion Gene Predicts A Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Single Center Study
摘要号：998 第一作者：魏志杰，通讯作者：魏志杰 题目：Haploidentical Hematopoietic Cell Transplantation with Unrelated Cord Blood Enhances Survival and Reduces the Incidence of aGVHD for Pediatric Acute Myeloid Leukemia
摘要号：1070 第一作者：董磊，通讯作者：曹星玉 题目：Analysis of the Efficacy of Luspatercept in the Treatment of Anemia after Allogeneic Haematopoietic Stem Cell Transplantation
摘要号：1074 第一作者：马薇，通讯作者：曹星玉 题目：Rituximab for the Treatment of Steroid-Refractory Oral Chronic Graft-Versus-Host Disease after Allo-Hematopoietic Stem Cell Transplantation
摘要号：1102 第一作者：潘飞，通讯作者：魏志杰 题目：Efficacy Analysis of Haploidentical Transplantation Using Busulfan/Cyclophosphamide and Melphalan as Conditioning Regimen for Relapsed and Refractory Acute Myeloid Leukemia
摘要号：1103 第一作者：胥方，通讯作者：卢岳 题目：Diagnosis of Mucormycosis in Allogeneic Hematopoietic Stem Cell Transplantation Using Metagenomic Next-Generation Sequencing: A Single-Center Clinical Study
摘要号：1306 第一作者：李楠楠，通讯作者：张建平 题目：Allogeneic Hematopoietic Stem Cell Transplantation with Bu(2)/Cy/Flu/ATG can Achieve Good Results in Treatment of Transfusion Dependent Non-Severe Aplastic Anemia
摘要号：1338 第一作者：孙瑞娟，通讯作者：孙瑞娟 题目：Comparisons of Safety and Efficacy of Allo-HSCT after CAR T-Cell or Chemotherapy-Based Complete Remission in Pediatric T-ALL
摘要号：1730 第一作者：王东出，通讯作者：王卉 题目：Relevant Studies on Cytokines Level and CAR-T Expansion Associated to CD7 CAR-T Therapy
摘要号：1743 第一作者：张建平，通讯作者：张建平 题目：ATLG has Better Safety than RATG in the Treatment of Adult AA with Allogeneic Hematopoietic Stem Cell Transplantation
摘要号：1748 第一作者：陈曼，通讯作者：王卉 题目：Stratification and Immunologic Analysis of Patients with SARS-CoV-2 Infection after Hematopoietic Stem Cell Transplantation
摘要号：1755 第一作者：张建平，通讯作者：张建平 题目：Study on The Efficacy and Safety of Blinatumomab Maintenance Therapy of High Risk Ph Negative ALL after Allo-HSCT
Note: The above research results are listed in order of abstract number